Study of Prognostic Factors of the Distal Epiphysis of the Tibia Fracture Prognosis
A Multi Center Study of Prognostic Factors of the Distal Epiphysis of the Tibia Fracture
1 other identifier
interventional
200
0 countries
N/A
Brief Summary
Background: Epiphysis of distal end of tibia fracture is quite common in children epiphysis injury, because of the complex damage mechanism and often leads to growth retardation and joint deformity, the patient's physical and mental damage larger; also epiphysis injury restoration requires higher standard and more difficult to fixed, and methods are being actively explored to improve the curative effect and prevent the sequelae. Our hospital pediatric department of orthopedics expects to conduct prospective study through multi center to study the influence of factors such as the tibia epiphysis fracture of distal injury's mechanism and initial and residual displacement and treatment etc. on patients' prognosis of late growth disorders, joint deformity and ankle function. Methods and analysis: To join the multi center research collaboration group of the south pediatric department of orthopedics (including Pediatric Department of orthopedics of Wuhan Union Hospital, Wuhan Tongji Hospital, Hunan Children's Hospital, Wuhan women and children's Hospital, Foshan Hospital of traditional Chinese medicine, Shenzhen children's Hospital, Guangzhou city women and children's Medical Center), the formation of multi center research network, writing program, including the inclusion and exclusion criteria, grouping and follow-up time, method. Participating in the working group meeting, listening to the expert's opinions to improve research programs, formulate the tracking table of distal tibial epiphyseal fracture, and starting to implement after approved by the medical ethics committee of each hospital. The hospital is responsible for supervision in the whole process of project implementation, and building the real-time reporting system, and it is the responsible person of pediatric department of orthopedics of Foshan Hospital of TCM to do the random inspection. After the completion of data collection, data entry and statistical analysis conducted by the pediatric department of orthopedics in Foshan Hospital of TCM. Ethics and promotion: The research is approved by the hospital medical ethics committee of the south pediatric orthopedics multi center cooperative research group. Single blind method is performed for children in the course of the study. Research data is shared by all participating units and joints promotion of research results. Registration: To register and update the study on the United States NIH ClinicalTrials.gov website.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2016
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 18, 2016
CompletedFirst Posted
Study publicly available on registry
March 31, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedMarch 31, 2016
March 1, 2016
5.8 years
March 18, 2016
March 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation criteria of OVADIA and the change over time
Excellent, Joint function restore basic consistent with that of the healthy side, without any symptoms, or joint flexion range is more than 75% of the healthy side, mild sore and swollen after walking, restore normal work; Good, joint flexion range is 50% - 70% of the healthy side, joint is mild soreness, markedly swollen after walking, unable to attend the heavy physical work; Can, joint flexion range is 25% - 50% of the healthy side, joint is obvious swelling and pain, difficulty walking, and accept joint arthrodesis at the end; Poor, joint range is less than 25% of the healthy side, joint is markedly swollen, pain, stiffness, unable to walk, and accept joint arthrodesis at the end.
1 year,2year,3year,4year,5year(We think that develops gradually of limb shortening or angle because of early epiphyseal closure will result in a lowered grad of OVADIA)
Secondary Outcomes (3)
Early closure of epiphysis
3 months,6 months,9months,12months
Limb shortening
1 year,2year,3year,4year,5year
Ankle joint function and the change over time
1 year,2year,3year,4year,5year(We think that develops gradually of limb shortening or angle because of early epiphyseal closure will also result in a lower score of AOFAS Ankle-Hindfoot Scale)
Study Arms (3)
Less or equal to 2mm
PLACEBO COMPARATORthe residual displacement is less than or equal to 2mm
Between 2-4mm
PLACEBO COMPARATORthe residual shift is between 2-4mm, manual reset once again, as still between 2-4mm
Greater than 4mm
ACTIVE COMPARATORthe residual displacement is greater than 4mm
Interventions
Treated with Manipulatio, using plywood, gypsum or external fixation support to fixed
Eligibility Criteria
You may qualify if:
- The fresh fractures, within 7 days
- Closed fracture
- Type S-H I or II
- Unilateral limb fracture, no other parts of the fractures or damage
- On the other side of the lower extremity was normal
- Epiphysis is not closed and Risser sign 0-IV degrees
- No metabolic, genetic sex diseases etc.
- Signed informed consent
You may not qualify if:
- Old fracture, more than 8 days.
- Open injury
- Type S-H III or IV or V
- Multiple fractures and injuries
- The contralateral limb was abnormal
- Epiphyseal closure or Risser sign V degree
- There are metabolic or genetic diseases
- Do not agree to sign informed consent, not on time to follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Russo F, Moor MA, Mubarak SJ, Pennock AT. Salter-Harris II fractures of the distal tibia: does surgical management reduce the risk of premature physeal closure? J Pediatr Orthop. 2013 Jul-Aug;33(5):524-9. doi: 10.1097/BPO.0b013e3182880279.
PMID: 23752150BACKGROUNDLeary JT, Handling M, Talerico M, Yong L, Bowe JA. Physeal fractures of the distal tibia: predictive factors of premature physeal closure and growth arrest. J Pediatr Orthop. 2009 Jun;29(4):356-61. doi: 10.1097/BPO.0b013e3181a6bfe8.
PMID: 19461377BACKGROUNDPodeszwa DA, Mubarak SJ. Physeal fractures of the distal tibia and fibula (Salter-Harris Type I, II, III, and IV fractures). J Pediatr Orthop. 2012 Jun;32 Suppl 1:S62-8. doi: 10.1097/BPO.0b013e318254c7e5.
PMID: 22588106RESULTGonc U, Kayaalp A. [Ankle fractures in children and adolescents]. Acta Orthop Traumatol Turc. 2004;38 Suppl 1:127-37. Turkish.
PMID: 15187469RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yueming Guo, benco
Director of pediatric orthopaedic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Head of Pediatric Department of Orthopedics,Clinical Professor of Guangzhou University of TCM
Study Record Dates
First Submitted
March 18, 2016
First Posted
March 31, 2016
Study Start
March 1, 2016
Primary Completion
December 1, 2021
Study Completion (Estimated)
December 1, 2026
Last Updated
March 31, 2016
Record last verified: 2016-03